Key facts
- LFCR - LIFECORE BIOMEDICAL, INC. \DE\ has 26 insiders with reported activity on this page.
- Net insider value flow over the last year: -$9,132,503.
- Recent transaction rows are available for direct filing-level review.
Insider Transactions Reported by 26 Insiders of LIFECORE BIOMEDICAL, INC. \DE\
- Symbol
- LFCR on Nasdaq
- Location
- Chaska, MN
Change
- Buy value: ; sell value: $9,132,502.
- Net share flow: -1,386,060.
Research use
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsNet insider flow leans to selling over the last 12 months. Net value: -$9,132,503.
Buys
$0
Shares: 0
Insiders: 0
Sells
$9,132,503
Shares: 1,386,060
Insiders: 1
Net
-$9,132,503
Shares: -1,386,060
Insiders: -1
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 1,386,060 | $0 | $9,132,503 | -$9,132,503 |
LIFECORE BIOMEDICAL, INC. \DE\ executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Christopher S. Kiper | Director, 10%+ Owner | $36,388,838 | Mixed | 15 Jul 2025 | ||
| WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 10%+ Owner | $19,283,185 | Filing P/S | 03 Oct 2024 | ||
| James G. Hall | Chief Executive Officer, Director | $2,876,920 | Mixed | 01 Jun 2023 | ||
| Ryan David Lake | Chief Financial Officer | $2,595,887 | Mixed | 03 Sep 2025 | ||
| Paul Josephs | Chief Executive Officer, Director | $2,205,643 | Median | 20 May 2026 | ||
| Aron R. English | 10%+ Owner | $1,881,965 | -$8,483,117 | -82% | Filing P/S | 23 May 2025 |
| John D. Morberg | Chief Financial Officer | $1,308,929 | Mixed | 18 Jan 2024 | ||
| Nelson Obus | Director | $1,122,140 | Mixed | 15 Jul 2025 | ||
| Craig A. Barbarosh | Director | $917,721 | Mixed | 08 Jul 2024 | ||
| Thomas D. Salus | Chief Legal & Administration | $916,457 | Median | 14 Apr 2026 | ||
| Katrina Houde Lovas | Director | $888,436 | Mixed | 15 Jul 2025 | ||
| Joshua Schechter | Director | $870,255 | Mixed | 15 Jul 2025 | ||
| Jeffrey L. Edwards | Director | $830,130 | Mixed | 08 Jul 2024 | ||
| Albert D. Bolles | Chief Executive Officer | $759,441 | Mixed | 23 May 2022 | ||
| Raymond H. Diradoorian | Director | $729,171 | Mixed | 08 Jul 2024 | ||
| Tonia L. Pankopf | Director | $621,022 | Mixed | 04 Jun 2022 | ||
| Nathaniel Calloway | Director | $605,079 | Mixed | 08 Jul 2024 | ||
| Catherine A. Sohn | Director | $563,399 | Mixed | 04 Jun 2022 | ||
| Humberto C. Antunes | Director | $382,131 | Mixed | 15 Jul 2025 | ||
| Deborah D. Carosella | Director | $381,247 | Mixed | 04 Jun 2022 | ||
| Paul H. Johnson | Director | $357,771 | Mixed | 15 Jul 2025 | ||
| Matthew E. Korenberg | Director | $357,771 | Mixed | 15 Jul 2025 | ||
| Jason Aryeh | Director | $357,771 | Mixed | 15 Jul 2025 | ||
| Andrew Kenneth William Powell | Director | $286,310 | Mixed | 04 Jun 2022 | ||
| Timothy P. Burgess | Senior VP of Supply Chain | $239,704 | Mixed | 27 Jul 2021 | ||
| Patrick D. Walsh | Director | $49,413 | Mixed | 04 Jun 2021 |
Top shareholders of LIFECORE BIOMEDICAL, INC. \DE\ (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Greenhaven Road Investment Management, L.P. |
13D/G
13F
|
Company |
9.8%
|
3,616,146
|
$22,998,689 | +$7,944,848 | 31 Dec 2024 | |
| 22NW Fund, LP |
13D/G
|
— |
7.5%
|
2,975,398
|
$20,768,278 | -$9,716,865 | 27 May 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
5%
from 13D/G
|
1,877,305
|
$6,983,574 | — | 31 Mar 2026 | |
| David Capital Partners, LLC |
13D/G
|
— |
4.9%
|
1,803,000
|
$11,467,080 | $0 | 31 Dec 2024 | |
| Christopher S. Kiper |
3/4/5
|
Director, 10%+ Owner |
12%
|
4,481,329
|
$36,388,838 | — | 15 Jul 2025 | |
| Aron R. English |
3/4/5
|
10%+ Owner |
0.7%
|
264,180
|
$1,881,965 | -$8,483,117 | 23 May 2025 | |
| Nelson Obus |
3/4/5
|
Director |
0.37%
|
138,193
|
$1,122,140 | — | 15 Jul 2025 | |
| Katrina Houde Lovas |
3/4/5
|
Director |
0.29%
|
109,412
|
$888,436 | — | 15 Jul 2025 | |
| Joshua Schechter |
3/4/5
|
Director |
0.29%
|
107,173
|
$870,255 | — | 15 Jul 2025 | |
| Humberto C. Antunes |
3/4/5
|
Director |
0.13%
|
47,060
|
$382,131 | — | 15 Jul 2025 | |
| Jason Aryeh |
3/4/5
|
Director |
0.12%
|
44,060
|
$357,771 | — | 15 Jul 2025 | |
| Matthew E. Korenberg |
3/4/5
|
Director |
0.12%
|
44,060
|
$357,771 | — | 15 Jul 2025 | |
| Paul H. Johnson |
3/4/5
|
Director |
0.12%
|
44,060
|
$357,771 | — | 15 Jul 2025 | |
| WYNNEFIELD CAPITAL INC |
13F
|
Company |
13%
|
4,703,216
|
$17,495,964 | — | 31 Mar 2026 | |
| Legion Partners Asset Management, LLC |
13F
|
Company |
12%
|
4,461,823
|
$16,597,982 | — | 31 Mar 2026 | |
| 325 CAPITAL LLC |
13F
|
Company |
5.8%
|
2,162,466
|
$8,044,374 | — | 31 Mar 2026 | |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
|
Company |
3.4%
|
1,290,136
|
$4,799,306 | — | 31 Mar 2026 | |
| GRIZZLYROCK CAPITAL, LLC |
13F
|
Company |
2.2%
|
827,488
|
$3,078,255 | — | 31 Mar 2026 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.2%
|
815,107
|
$3,033,000 | — | 31 Mar 2026 | |
| MORGAN STANLEY |
13F
|
Company |
2%
|
764,734
|
$2,844,812 | — | 31 Mar 2026 | |
| STATE STREET CORP |
13F
|
Company |
1.7%
|
642,006
|
$2,388,262 | — | 31 Mar 2026 | |
| Quinn Opportunity Partners LLC |
13F
|
Company |
1.2%
|
453,495
|
$1,687,001 | — | 31 Mar 2026 | |
| DCF Advisers, LLC |
13F
|
Company |
1.1%
|
424,500
|
$1,579,140 | — | 31 Mar 2026 | |
| WITTENBERG INVESTMENT MANAGEMENT, INC. |
13F
|
Company |
0.8%
|
301,815
|
$1,122,752 | — | 31 Mar 2026 | |
| VANGUARD FIDUCIARY TRUST CO |
13F
|
Company |
0.63%
|
237,065
|
$881,882 | — | 31 Mar 2026 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.61%
|
228,158
|
$848,748 | — | 31 Mar 2026 | |
| LPL Financial LLC |
13F
|
Company |
0.55%
|
207,790
|
$772,979 | — | 31 Mar 2026 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.45%
|
168,376
|
$626,359 | — | 31 Mar 2026 | |
| VANGUARD PORTFOLIO MANAGEMENT LLC |
13F
|
Company |
0.44%
|
164,560
|
$612,163 | — | 31 Mar 2026 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.42%
|
157,157
|
$584,624 | — | 31 Mar 2026 | |
| TOCQUEVILLE ASSET MANAGEMENT L.P. |
13F
|
Company |
0.4%
|
151,700
|
$564,324 | — | 31 Mar 2026 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.34%
|
125,750
|
$468,000 | — | 31 Mar 2026 | |
| Diametric Capital, LP |
13F
|
Company |
0.28%
|
105,149
|
$391,154 | — | 31 Mar 2026 | |
| GAMCO INVESTORS, INC. ET AL |
13F
|
Company |
0.22%
|
83,800
|
$311,736 | — | 31 Mar 2026 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.21%
|
79,978
|
$297,518 | — | 31 Mar 2026 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.2%
|
75,097
|
$279,361 | — | 31 Mar 2026 | |
| DBA TRADING, LLC |
13F
|
Company |
0.2%
|
75,000
|
$279,000 | — | 31 Mar 2026 | |
| UBS Group AG |
13F
|
Company |
0.19%
|
69,992
|
$260,370 | — | 31 Mar 2026 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.16%
|
61,800
|
$229,896 | — | 31 Mar 2026 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.16%
|
58,466
|
$217,493 | — | 31 Mar 2026 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.16%
|
58,354
|
$217,078 | — | 31 Mar 2026 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.14%
|
52,404
|
$194,943 | — | 31 Mar 2026 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.12%
|
43,298
|
$161,068 | — | 31 Mar 2026 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.11%
|
40,789
|
$151,735 | — | 31 Mar 2026 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.1%
|
36,261
|
$134,891 | — | 31 Mar 2026 | |
| Nuveen, LLC |
13F
|
Company |
0.1%
|
35,850
|
$133,362 | — | 31 Mar 2026 | |
| Steward Partners Investment Advisory, LLC |
13F
|
Company |
0.09%
|
34,277
|
$127,510 | — | 31 Mar 2026 | |
| Jefferies Financial Group Inc. |
13F
|
Company |
0.09%
|
32,500
|
$120,900 | — | 31 Mar 2026 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.09%
|
32,258
|
$119,991 | — | 31 Mar 2026 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.07%
|
25,427
|
$94,588 | — | 31 Mar 2026 |
Recent Insider Transactions by Companies or Individuals for LIFECORE BIOMEDICAL, INC. \DE\
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Paul Josephs | LFCR | Common Stock | Tax liability | -6.38% | -40,413 | 592,915 | 20 May 2026 | Direct | ||
| Thomas D. Salus | LFCR | Common Stock | Tax liability | -9.09% | -24,645 | 246,333 | 14 Apr 2026 | Direct | ||
| Thomas D. Salus | LFCR | Common Stock | Award | 12.4% | 30,000 | 270,978 | 02 Mar 2026 | Direct | ||
| Ryan David Lake | LFCR | Common Stock | Tax liability | -6.38% | -22,932 | 336,691 | 03 Sep 2025 | Direct | ||
| Nelson Obus | LFCR | Common Stock | Award | 16.4% | 19,506 | 138,193 | 15 Jul 2025 | Direct | ||
| Christopher S. Kiper | LFCR | Common Stock | Award | 33.6% | 19,506 | 77,575 | 15 Jul 2025 | Direct | ||
| Paul H. Johnson | LFCR | Common Stock | Award | 79.4% | 19,506 | 44,060 | 15 Jul 2025 | Direct | ||
| Jason Aryeh | LFCR | Common Stock | Award | 79.4% | 19,506 | 44,060 | 15 Jul 2025 | Direct | ||
| Matthew E. Korenberg | LFCR | Common Stock | Award | 79.4% | 19,506 | 44,060 | 15 Jul 2025 | Direct | ||
| Humberto C. Antunes | LFCR | Common Stock | Award | 70.8% | 19,506 | 47,060 | 15 Jul 2025 | Direct | ||
| Joshua Schechter | LFCR | Common Stock | Award | 22.2% | 19,506 | 107,173 | 15 Jul 2025 | Direct | ||
| Katrina Houde Lovas | LFCR | Common Stock | Award | 21.7% | 19,506 | 109,412 | 15 Jul 2025 | Direct | ||
| Thomas D. Salus | LFCR | Common Stock | Tax liability | -4.37% | -11,022 | 240,978 | 08 Jul 2025 | Direct | ||
| Thomas D. Salus | LFCR | Common Stock | Options Exercise | 17.2% | 37,000 | 252,000 | 08 Jul 2025 | Direct | ||
| Thomas D. Salus | LFCR | Performance-Based Restricted Stock Units | Options Exercise | -10% | -37,000 | 333,000 | 08 Jul 2025 | Direct | ||
| Ryan David Lake | LFCR | Common Stock | Tax liability | -8.36% | -32,806 | 359,623 | 08 Jul 2025 | Direct | ||
| Ryan David Lake | LFCR | Common Stock | Options Exercise | 23.6% | 75,000 | 392,429 | 08 Jul 2025 | Direct | ||
| Ryan David Lake | LFCR | Performance-Based Restricted Stock Units | Options Exercise | -11.1% | -75,000 | 600,000 | 08 Jul 2025 | Direct | ||
| Paul Josephs | LFCR | Common Stock | Tax liability | -7.97% | -54,857 | 633,328 | 08 Jul 2025 | Direct | ||
| Paul Josephs | LFCR | Common Stock | Options Exercise | 27.9% | 150,000 | 688,185 | 08 Jul 2025 | Direct | ||
| Paul Josephs | LFCR | Performance-Based Restricted Stock Units | Options Exercise | -10% | -150,000 | 1,350,000 | 08 Jul 2025 | Direct | ||
| Aron R. English | LFCR | Common Stock | Sale | -36.3% | $1,071,555 | $7.12 | -150,419 | 264,180 | 28 May 2025 | By: 22NW Fund, LP |
| Aron R. English | LFCR | Common Stock | Sale | -73.3% | $7,411,562 | $6.50 | -1,139,504 | 414,599 | 27 May 2025 | By: 22NW Fund, LP |
| Aron R. English | LFCR | Common Stock | Sale | -5.83% | $649,386 | $6.75 | -96,137 | 1,554,103 | 23 May 2025 | By: 22NW Fund, LP |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.